Sara Van Den Bossche
Gent, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Identification of DksA as a novel pro-inflammatory mediator of Pseudomonas aeruginosa under conditions mimicking chronic cystic fibrosis lung infection.
Journal: Virulence
Published: May 12, 2026
Unraveling the immunosuppressive role of Elastase B produced by cystic fibrosis isolates of Pseudomonas aeruginosa in an organotypic 3D lung epithelial cell model.
Journal: Virulence
Published: November 06, 2025
The development and characterization of in vivo-like three-dimensional models of bronchial epithelial cell lines.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: June 06, 2023
Commensal bacteria of the lung microbiota synergistically inhibit inflammation in a three-dimensional epithelial cell model.
Journal: Frontiers in immunology
Published: February 28, 2023
High throughput determination of the biofilm prevention concentration for Pseudomonas aeruginosa biofilms using a synthetic cystic fibrosis sputum medium.
Journal: Biofilm
Published: September 27, 2022
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects.
Journal: European respiratory review : an official journal of the European Respiratory Society
Published: March 08, 2021
Bacterial Interference With Lactate Dehydrogenase Assay Leads to an Underestimation of Cytotoxicity.
Bacterial Interference With Lactate Dehydrogenase Assay Leads to an Underestimation of Cytotoxicity.
Journal: Frontiers in cellular and infection microbiology
Published: April 17, 2020
The Antimicrobial Peptide lin-SB056-1 and Its Dendrimeric Derivative Prevent Pseudomonas aeruginosa Biofilm Formation in Physiologically Relevant Models of Chronic Infections.
Journal: Frontiers in microbiology
Published: November 12, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026